The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
dabigatran etexilate · Pellet
7 marketed package NDCs · 2 active manufacturers
Most dispensed: MESYLATE 150 mg · Capsule · #60 capsules/bottle · MESYLATE 75 mg · Capsule · #60 capsules/bottle · MESYLATE 110 mg · Capsule · #60 capsules/bottle · MESYLATE 150 mg · Capsule · #10 blister packs/carton / 6 capsule in 1 blister pack
What changed in the last 90 days
Every detected change for dabigatran etexilate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Dabigatran EtexilateAug 19, 2026Price downNADAC $0.85276 → $0.82255 per unit (-3.54%)
- DabigatranAug 19, 2026Price downNADAC $0.85276 → $0.82255 per unit (-3.54%)
- DabigatranAug 19, 2026Price downNADAC $0.97371 → $0.94602 per unit (-2.84%)
- DabigatranAug 19, 2026Price downNADAC $0.89859 → $0.84296 per unit (-6.19%)
- Dabigatran EtexilateAug 19, 2026Price downNADAC $0.97371 → $0.94602 per unit (-2.84%)
- Dabigatran EtexilateAug 19, 2026Price downNADAC $0.85276 → $0.82255 per unit (-3.54%)
- Dabigatran EtexilateAug 19, 2026Price downNADAC $0.89859 → $0.84296 per unit (-6.19%)
- Dabigatran EtexilateAug 19, 2026Price downNADAC $0.85276 → $0.82255 per unit (-3.54%)
- Dabigatran EtexilateAug 19, 2026Price downNADAC $0.85276 → $0.82255 per unit (-3.54%)
- Dabigatran EtexilateAug 19, 2026Price downNADAC $0.97371 → $0.94602 per unit (-2.84%)
Same drug class
Other molecules FDA puts in Direct Thrombin Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Dabigatran etexilate in shortage right now?
- No. FDA does not currently list Dabigatran etexilate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Dabigatran etexilate?
- 18 companies have marketed Dabigatran etexilate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Dabigatran etexilate cost?
- The typical pharmacy pays about $0.8430 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.